Caring for Leukemia Patients Takes a Heavy Toll on Family Caregivers, Global Survey Finds

A leukemia diagnosis ripples far beyond the hospital ward. According to a sweeping international survey published in Frontiers in Hematology, more than a third of the family members and partners who quietly shoulder the daily care of people with leukemia report a quality-of-life impact so severe it crosses a critical clinical threshold — and the burden differs dramatically depending on whether the disease is acute or chronic.

The study, led by researchers at Picker Institute Europe, the Acute Leukaemia Advocates Network, and the University of Hertfordshire, analyzed responses from 511 adult informal carers recruited through three global leukemia patient advocacy networks. Participants completed the Family Reported Outcome Measure, or FROM-16, a validated 16-item questionnaire that takes roughly two minutes to finish and scores the impact of a loved one’s illness on a caregiver’s quality of life from 0 to 32. Higher scores signal greater harm, and a score of 17 or above marks what researchers classify as a very large effect.

The headline numbers are stark. The median FROM-16 score across all respondents was 14, and 38 percent of carers — 195 out of 511 — scored above the critical threshold of 17. Women made up 73 percent of respondents, and the average carer age was 48.1 years. Roughly 59 percent supported someone with acute leukemia, while 41 percent cared for a person with a chronic form of the disease.

But the most striking finding emerged when researchers stratified results by leukemia type. Carers of people with acute leukemia reported a median FROM-16 score of 16, compared with just 8 for those supporting chronic leukemia patients — a gap corresponding to a moderate-to-large effect size, with leukemia type explaining 12.2 percent of the variance in scores (η² = 0.122, p = 2.92E−15). Nearly half of acute-group carers (47 percent) exceeded the very-large-effect threshold, versus 25 percent in the chronic group. Acute leukemia, which progresses rapidly and demands urgent, intensive intervention, appears to impose a distinctly heavier toll on those who care for its victims.

The single strongest predictor of caregiver quality of life, in both groups, was the sheer number of hours devoted to care each week. Among carers of acute leukemia patients, caregiving hours explained 13 percent of the variance in FROM-16 scores (η² = 0.130, p = 5.32E−6); among chronic-group carers, the figure soared to 23.2 percent (η² = 0.232, p = 5.65E−7) — a very large effect. Those providing 50 or more hours per week reported median scores of 20 in the acute group and 19 in the chronic group, while those giving less than one hour weekly reported medians of 12 and 3.5 respectively. More than half of acute-group carers (52 percent) provided 50 or more hours of care weekly, compared with just 15 percent of chronic-group carers.

The nature of the caregiving tasks also mattered. Administering medication was associated with moderate effect sizes in both groups (acute: η² = 0.071; chronic: η² = 0.094), while providing personal care — bathing, dressing, and other intimate support — showed small-to-moderate effects (acute: η² = 0.036; chronic: η² = 0.092). In the chronic group, shopping support carried a moderate-to-large effect (η² = 0.119), possibly reflecting the cumulative strain of ongoing, open-ended assistance. In the acute group, childcare (η² = 0.037) and managing finances (η² = 0.056) emerged as significant burdens, likely echoing the disruptive, urgent character of acute disease.

Communication quality proved especially consequential for chronic-group carers. Those who said the diagnosis was not explained in a way they could understand reported a median FROM-16 score of 22.5, compared with 7 for those who felt it was completely explained — a very large effect (η² = 0.151, p = 6.22E−5). Similarly, carers who always had to ask for test results to be explained reported a median score of 18, versus 6 for those who did not (η² = 0.121, p = 1.29E−5). Nearly seven in ten respondents across the survey said they needed to request explanations of test results, and 17 percent said they were never directed to any additional information or support resources.

The demographic patterns add another layer. In the acute group, female carers reported higher median scores (17) than male carers (14), full-time carers unable to work due to caregiving responsibilities reported the highest median of all (21), and adult sons and daughters caring for a parent reported a median of 20 — all statistically significant after Bonferroni adjustment. In the chronic group, no demographic variable reached significance, suggesting that for slowly progressing disease, the burden is driven more by care intensity and communication than by who the carer is.

The economic stakes are considerable. The study’s authors note that the 2021 UK census identified 5.8 million unpaid carers, of whom an estimated 1.1 million of working age care for someone with cancer, at an estimated annual wage cost of £8.58 billion. Informal carers collectively contribute an estimated £184.3 billion annually to the UK economy, with 1.5 million people providing more than 50 hours of care each week. Beyond economics, caregiver distress can adversely affect patient outcomes, treatment adherence, and healthcare utilization — a 2018 systematic review identified seven domains of unmet carer needs spanning information, physical, psychological, financial, service, spiritual, and social support.

The researchers argue their findings point toward differentiated support strategies. Carers of acute leukemia patients may benefit most from targeted respite services and financial guidance, while those supporting chronic leukemia patients may require sustained emotional and logistical support over the long term. The FROM-16’s brevity means clinicians could routinely deploy it in practice to identify families at risk of distress and inform shared decision-making. The authors caution that their cross-sectional design captures associations, not causation, and that their convenience sample — drawn largely from advocacy-connected populations across 14 languages — may not fully represent carers outside these networks or in regions with limited internet access. Still, the message is clear: informal carers are integral members of the leukemia care team, and their wellbeing deserves a formal place in care pathways, service design, and policy.

Subject of Research: Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey

Article Title: Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey

Article References: Poots, A. J., Nier, S., Gunn, S., & Salek, S. (2026). Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey. Frontiers in Hematology, 5, Article 1813321. https://doi.org/10.3389/frhem.2026.1813321

Image Credits: AI Generated

DOI: 10.3389/frhem.2026.1813321

Keywords: Associations, quality, life, adult, family, members, partners, informal, carers, people, leukaemia, results